Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTACT feasibility study of intravenous iron in critical care survivors with anaemia
2018-000767-91Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ferric carboxymaltose in anaemia, sponsored by University of Oxford. Primary endpoint: Feasibility of a future multicentre trial. Started Jun 2018; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
anaemia
Beyond the preview
Go deeper on 2018-000767-91.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000767-91.